This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chiba University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Atsushi Kasamatsu: Innovator in Cancer Chemotherapy
Introduction
Atsushi Kasamatsu is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of cancer treatment through his innovative methods. His work focuses on improving the effectiveness of chemotherapy, particularly with the anticancer drug S-1.
Latest Patents
Atsushi Kasamatsu holds a patent for a method of determining the administration effect in cancer chemotherapy with S-1. This method allows for a quick, simple, and accurate assessment of the therapeutic effect of S-1, which is a blend of three active ingredients: tegafur, gimeracil, and oteracil potassium. The patented method involves measuring the expression level of a decorin gene in a biological sample from the patient and determining the administration effect based on this measurement.
Career Highlights
Atsushi Kasamatsu is affiliated with Chiba University, where he conducts research and develops innovative solutions for cancer treatment. His work has the potential to enhance the effectiveness of chemotherapy and improve patient outcomes.
Collaborations
Atsushi collaborates with esteemed colleagues, including Hideki Tanzawa and Katsuhiro Uzawa. Their combined expertise contributes to advancements in cancer research and treatment methodologies.
Conclusion
Atsushi Kasamatsu is a pioneering inventor whose work in cancer chemotherapy is making a significant impact. His innovative methods are paving the way for more effective treatment options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile